STOCK TITAN

Praetorian Fund and Affiliates Disclose INMB Holdings of up to 3.4%

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Inmune Bio's Schedule 13G/A shows Praetorian-related entities holding disclosed positions in the company's common stock. Praetorian Capital Fund LLC directly beneficially owns 771,200 shares—comprised of 180,800 shares issuable upon warrants and 590,400 shares underlying call options exercisable within 60 days—representing approximately 2.9% of the class based on 26,585,258 shares outstanding. Mongolia (Barbados) Corp. directly owns 150,000 shares underlying call options 0.6%), and Harris Kupperman may be deemed to beneficially own a combined 921,200 shares 3.4%).

The filing identifies the reporting persons' roles

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Praetorian-related entities disclose a modest passive stake in INMB totaling up to 3.4% via warrants and options.

The filing provides a clear instrument-level breakdown: 771,200 shares for Praetorian Fund, including 180,800 warrants and 590,400 call-option shares, plus 150,000 shares held by Mongolia, measured against a 26,585,258 share base. Reported percentages 2.9%, Mongolia ~0.6%, combined Kupperman ~3.4%) are below the 5% threshold referenced in the filing, implying limited immediate market impact. The identification of instruments exercisable within 60 days is material for potential dilution and voting exposure if exercised.

TL;DR: Reporting persons characterize positions as non-control and provide standard Schedule 13G disclosure for transparency.

The statement names each reporting entity and their relationships 2.9%, Mongolia ~0.6%, Kupperman combined ~3.4%), the filing aligns with passive investor reporting under Schedule 13G rather than an active control filing.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Praetorian PR LLC
Signature:/s/ Harris Kupperman
Name/Title:Harris Kupperman, Managing Member
Date:08/14/2025
Praetorian Capital Fund LLC
Signature:/s/ Harris Kupperman
Name/Title:Harris Kupperman, Managing Member of its Manager
Date:08/14/2025
Praetorian Capital Management LLC
Signature:/s/ Harris Kupperman
Name/Title:Harris Kupperman, Managing Member
Date:08/14/2025
Mongolia (Barbados) Corp.
Signature:/s/ Genevieve Walkden Jackson
Name/Title:Genevieve Walkden Jackson, Chief Financial Officer of its Controlling Person and Sole Shareholder
Date:08/14/2025
Mongolia Growth Group Ltd.
Signature:/s/ Harris Kupperman
Name/Title:Harris Kupperman, CEO and Executive Chairman
Date:08/14/2025
Kupperman Harris
Signature:/s/ Harris Kupperman
Name/Title:Harris Kupperman
Date:08/14/2025

FAQ

How many INMB shares does Praetorian Capital Fund LLC beneficially own?

Praetorian Capital Fund LLC beneficially owns 771,200 shares, consisting of 180,800 shares issuable upon warrants and 590,400 shares underlying call options exercisable within 60 days.

What percentage of INMB does Praetorian Fund own?

Praetorian Fund's position represents approximately 2.9% of the outstanding shares based on a 26,585,258 share base disclosed in the filing.

How many INMB shares does Mongolia (Barbados) Corp. hold?

Mongolia (Barbados) Corp. directly beneficially owns 150,000 shares underlying call options, representing about 0.6% of the class.

What is Harris Kupperman's reported beneficial ownership of INMB?

Harris Kupperman may be deemed to beneficially own a combined 921,200 shares 3.4%), reflecting holdings attributable to Praetorian entities and Mongolia as described in the filing.

Were the INMB securities acquired to influence control of the company?

The filing includes a certification stating the securities were not acquired and are not held for the purpose of changing or influencing control of the issuer.
Inmune Bio Inc

NASDAQ:INMB

INMB Rankings

INMB Latest News

INMB Latest SEC Filings

INMB Stock Data

39.88M
22.04M
24.61%
21.21%
14.06%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
BOCA RATON